COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Post by testfreakon Sep 08, 2015 1:08pm

116 Views

Post# 24085961

Level 2 ask thin

Big announcement coming. Oversold and gonna rocket when shorts cover.

LEVEL 2 QUOTE

Shares	Bid Price	Ask Price	Shares
417,000	0.100	0.105	30,000
65,000	0.095	0.110	112,000
177,000	0.090	0.115	158,000
38,500	0.085	0.120	156,500
98,500	0.080	0.125	55,500
59,500	0.075	0.130	29,500
39,500	0.070	0.135	36,000
7,500	0.065	0.140	34,500
44,000	0.060	0.145	10,000
5,000	0.055	0.150